Biatrial global high-density electroanatomical mapping of atrial fibrillation – a prospective mechanistic registry study

Oxford University Hospitals NHS Foundation Trust0 个研究点目标入组 22 人开始时间: 2018年9月28日最近更新: 2021年6月14日

适应症

试验速览

暂无简介。

•1. Participant is willing and able to give informed consent for participation in the trial
•2. Male or female, aged 18 years or above
•3. Diagnosed with paroxysmal or persistent atrial fibrillation and planned for a catheter ablation procedure
•4. In the Investigator’s opinion is able and willing to comply with all trial requirements

•1. Physical or anatomical barriers to the use of two simultaneous mapping catheters
•2. Previous cardiac surgery
•3. Previous ablation (catheter or surgical)
•4. Female participant who is pregnant, lactating or planning pregnancy during the course of the trial
•5. Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the trial, or may influence the result of the trial, or the participant’s ability to participate in the trial
•6. Participants who have participated in another research trial involving an investigational medicinal product in the past 12 weeks. (Involvement in any other research trial is not a contraindication per se)

发起方

Oxford University Hospitals NHS Foundation Trust